backThe world of digital health is expanding at an exponential rate, and one key area is that of software applications that are directed at women, aka femtech.
Questions abound in this novel area, from FDA regulatory issues, state law issues, and Anti-Kickback Statute issues to privacy issues and questions unique to femtech apps that are intended to be used with prescription drugs.
King & Spalding hosted a one-hour roundtable webinar on February 24, 2022, to discuss this rapidly evolving area and implications for femtech developers. Topics for discussion included:
-
Threshold regulatory questions to ask when launching a femtech start-up;
-
FDA and state law regulation of digital health tools, including femtech;
-
Gray areas, areas of risk to watch out for and potential risk mitigation strategies; and
-
Use of femtech software in health-related communications and communications related to prescription drug use.
If you have questions concerning this roundtable webinar, email Chayako Williams at cbwilliams@kslaw.com.
CLE
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, garias@kslaw.com. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.